Immunogenicity of a hepatitis B subunit vaccine in hemodialysis and in renal transplant recipients
- 1 March 1983
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 3 (1) , 43-52
- https://doi.org/10.1016/0166-3542(83)90013-x
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final reportHepatology, 1981
- RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: II, HAEMODIALYSIS PATIENTSThe Lancet, 1981
- PASSIVE.ACTIVE IMMUNISATION AGAINST HEPATITIS B: IMMUNOGENICITY STUDIES IN ADULT AMERICANSThe Lancet, 1981
- Heat-inactivated HBsAg as a vaccine against hepatitis BAntiviral Research, 1981
- EFFICACY OF HEPATITIS B VACCINE IN PREVENTION OF EARLY HBsAg CARRIER STATE IN CHILDREN Controlled Trial in an Endemic Area (Senegal)The Lancet, 1981
- RANDOMISED PLACEBO-CONTROLLED TRIAL OF HEPATITIS B SURFACE ANTIGEN VACCINE IN FRENCH HAEMODIALYSIS UNITS: I, MEDICAL STAFFThe Lancet, 1981
- Hepatitis B VaccineNew England Journal of Medicine, 1980
- Large‐scale efficacy trials of hepatitis B vaccines in the USA: Baseline data and protocolsJournal of Medical Virology, 1979
- Vaccine against hepatitis B — 18 months prevention in a high risk settingMedical Microbiology and Immunology, 1978
- Purified and inactivated human hepatitis B vaccineThe Lancet Healthy Longevity, 1975